ContributorsPublishersAdvertisers

Dr. Shah and Dr. Wang on Managing CRS and Neurotoxicity in Leukemia/Lymphoma

onclive.com
 2021-11-24

Bijal Shah, MD, Moffit Cancer Center, Michael L. Wang, MD University of Texas MD Anderson Cancer Center. Bijal Shah, MD, MS, and Michael Wang, MD, discuss management strategies for CAR T-cell therapy–related cytokine release syndrome and neurotoxicity in leukemia and lymphoma. Bijal Shah, MD, MS, associate...

www.onclive.com

Comments / 0

Comments / 0